Medicare Enrolled
Dr. Melissa Rhodes, M.D.
Critical Care Medicine · Cartersville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rhodes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rhodes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rhodes
Dr. Melissa Rhodes is a critical care medicine specialist in Cartersville, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Rhodes performed 3,082 Medicare services across 1,871 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rhodes received a total of $14,403 from 55 pharmaceutical and/or device companies across 634 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rhodes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 5% volume in GA
$14,403 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,082
Medicare services
Top 5% in GA for critical care medicine
1,871
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~147 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
558 | $92 | $276 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
395 | $65 | $203 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
391 | $27 | $116 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
335 | $92 | $246 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
323 | $61 | $166 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
217 | $38 | $119 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
174 | $40 | $116 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
93 | $134 | $410 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
85 | $25 | $73 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
84 | $155 | $596 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
75 | $52 | $152 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $123 | $412 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
71 | $29 | $69 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
68 | $76 | $179 |
| New patient office visit, complex (60-74 min) | 41 | $143 | $470 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
38 | $69 | $518 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
27 | $18 | $48 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
20 | $2 | $5 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
13 | $17 | $64 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,403
Total received (2018-2024)
Avg $2,058/year across 7 years
Top 10% in GA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
634
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,718 (81.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,685 (18.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,593
2023
$1,614
2022
$1,457
2021
$1,698
2020
$3,994
2019
$1,989
2018
$2,058
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$333
AstraZeneca Pharmaceuticals LP
$237
GlaxoSmithKline, LLC.
$113
GENZYME CORPORATION
$104
United Therapeutics Corporation
$104
Merck Sharp & Dohme LLC
$98
Regeneron Healthcare Solutions, Inc.
$94
Amgen Inc.
$62
Actelion Pharmaceuticals US, Inc.
$60
Mallinckrodt Hospital Products Inc.
$60
Mylan Specialty L.P.
$54
Resmed Corp
$47
Philips North America LLC
$40
ANI Pharmaceuticals, Inc.
$40
Grifols USA, LLC
$37
HARMONY BIOSCIENCES LLC
$27
Vifor Pharma, Inc.
$24
Fisher & Paykel Healthcare Inc
$21
ABBVIE INC.
$19
Axsome Therapeutics, Inc.
$18
Top 3 companies account for 42.9% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,966
GlaxoSmithKline, LLC.
$1,809
AstraZeneca Pharmaceuticals LP
$1,232
Jazz Pharmaceuticals Inc.
$1,130
Grifols USA, LLC
$775
Mylan Specialty L.P.
$657
United Therapeutics Corporation
$547
GENZYME CORPORATION
$516
Actelion Pharmaceuticals US, Inc.
$503
Mallinckrodt Hospital Products Inc.
$490
Regeneron Healthcare Solutions, Inc.
$366
Sunovion Pharmaceuticals Inc.
$309
Genentech USA, Inc.
$268
Insmed, Inc.
$220
Teva Pharmaceuticals USA, Inc.
$197
JAZZ PHARMACEUTICALS INC.
$168
Allergan, Inc.
$155
Gilead Sciences, Inc.
$137
Amgen Inc.
$136
Merck Sharp & Dohme LLC
$133
Bayer HealthCare Pharmaceuticals Inc.
$128
ANI Pharmaceuticals, Inc.
$102
Advanced Respiratory, Inc
$102
Mallinckrodt LLC
$99
PFIZER INC.
$79
Resmed Corp
$77
Eisai Inc.
$76
Circassia Pharmaceuticals Inc
$63
Covis Pharma GmBH
$61
Electromed, Inc.
$61
Fisher & Paykel Healthcare Inc
$60
Shire North American Group Inc
$57
PORTOLA PHARMACEUTICALS, INC.
$56
Allergan Inc.
$50
ABBVIE INC.
$48
Harmony Biosciences LLC
$48
Takeda Pharmaceuticals U.S.A., Inc.
$44
Philips North America LLC
$40
Merck Sharp & Dohme Corporation
$40
AbbVie Inc.
$35
Inspire Medical Systems, Inc.
$35
La Jolla Pharmaceutical Company
$32
Janssen Pharmaceuticals, Inc
$32
Pulmonx Corporation
$31
Inogen, Inc.
$30
Philips Electronics North America Corporation
$30
Mallinckrodt Enterprises LLC
$29
HARMONY BIOSCIENCES LLC
$27
Vifor Pharma, Inc.
$24
Novo Nordisk Inc
$18
Axsome Therapeutics, Inc.
$18
Olympus America Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$14
Novartis Pharmaceuticals Corporation
$14
Alexion Pharmaceuticals, Inc.
$13
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (8874) inCourage · (AK6) Vest Therapy · 120V · 60Hz · ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BOTOX · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · CINQAIR · COMBIVENT RESPIMAT · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Dymista · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · GIAPREZA · GLASSIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Ozempic · POMPE - DISEASE · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PT100US/myAIRVO 2 · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · ULTOMIRIS · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for critical care medicine in GA.
Geographic Context
Critical care medicines within 10 mi
5
Per 100K population
4.5
County median income
$79,431
Nearest hospital
PIEDMONT CARTERSVILLE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rhodes is a clinical cardiology specialist, with above-average Medicare volume (top 5% in GA), with low-engagement industry engagement in the top 10% of GA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rhodes experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rhodes performed 558 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rhodes receive payments from pharmaceutical companies?
Yes. Dr. Rhodes received a total of $14,403 from 55 companies across 634 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rhodes's costs compare to other critical care medicines in Cartersville?
Dr. Rhodes's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rhodes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Cartersville
Browse critical care medicines in Cartersville ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in GA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in GA
Which GA critical care medicines receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology